跳至主要内容
临床试验/NCT05338008
NCT05338008已完成不适用

Serum and Wound Vancomycin Levels Following Intrawound Administration in Primary Total Hip Arthroplasty

The Affiliated Hospital of Qingdao University1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2022年5月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
120
试验地点
1
主要终点
Blood loss

研究概览

简要总结

The purpose of this study is to determine the intra-articular and serum levels of vancomycin over the first 24 hours postoperatively after intra-articular administration of a standard dose of vancomycin in primary total hip arthroplasty.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age over 18;
  • Total hip arthroplasty for advanced hip diseases including femoral neck fracture, developmental dysplasia of hip, and osteonecrosis of the femoral head.

排除标准

  • Diminished mental capacity
  • Vancomycin allergy
  • Chronic kidney disease stage III and stage IV

结局指标

主要结局

Blood loss

时间窗: Postoperative Day 3

Renal function

时间窗: Postoperative Day 1 and Day 3

blood urea nitrogen (BUN), creatinine (Cr), GFR

Intra-articular vancomycin concentration

时间窗: 2 hours, 8 hours and 24 hours postoperatively

Serum vancomycin concentration

时间窗: 2 hours, 8 hours and 24 hours postoperatively

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Xiang Shuai, MD

Principal Investigator

The Affiliated Hospital of Qingdao University

研究点 (1)

Loading locations...

相似试验

Intrawound Administration of Vancomycin in THA | 临床试验